Vanda Pharmaceuticals Inc (VNDA) is a biotechnology company listed on NASDAQ.
Latest reported VNDA revenue for 2026-06-30 was $102.2M. Net income was -$111.1M. Revenue was up 97.7% from 2026-03-31 to 2026-06-30. VNDA currently screens at market cap $358.4M.
Use this VNDA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the VNDA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the VNDA SEC filings page. Lician reads the product cache first so this HTML stays unique to Vanda Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full VNDA income, balance, and cash tables.